CD44 and cancer: How these ID proteins maintain the cancer stem-cell phenotype is not known, but the response of GCSCs to TGF-β receptor inhibitors by reducing ID1, ID3 proteins and cell surface CD44 is very important as such markers appear to be functionally linked to the cancer-initiating phenotype of GCSCs [145].